Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00128
|
|||||
| Drug Name |
Methylprednisolone
|
|||||
| Synonyms |
Depo-medrol; M-predrol; Medrol; Medrol Acetate; Methylprednisolone Acetate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Chronic obstructive pulmonary disease [ICD11: CA22] | Approved | [1] | |||
| Asthma [ICD11: CA23] | Approved | [1] | ||||
| Tuberculosis [ICD11: 1B1Z] | Approved | [1] | ||||
| Systemic lupus erythematosus [ICD11: 4A40.0] | Approved | [1] | ||||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C22H30O5
|
|||||
| Canonical SMILES |
CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
|
|||||
| InChI |
InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1
|
|||||
| InChIKey |
VHRSUDSXCMQTMA-PJHHCJLFSA-N
|
|||||
| CAS Number |
CAS 83-43-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 374.5 | Topological Polar Surface Area | 94.8 | ||
| Heavy Atom Count | 27 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
1.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103189214
, 10321588
, 103914078
, 11406050
, 11466307
, 11467427
, 11486113
, 12159225
, 14779784
, 14853277
, 24870169
, 24896564
, 29225690
, 46504885
, 47440566
, 47589248
, 48259526
, 48334797
, 48416259
, 49698417
, 50019481
, 50104073
, 50139236
, 50796061
, 53790220
, 56311264
, 56311302
, 56311303
, 56311483
, 56312634
, 56313960
, 56313963
, 56314026
, 56314034
, 56424125
, 57323679
, 57650805
, 7847473
, 7979947
, 81093211
, 811679
, 8154374
, 82706
, 85300841
, 855789
, 85788445
, 87560014
, 92125124
, 92309029
, 93576705
|
|||||
| ChEBI ID |
ChEBI:6888
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Methylprednisolone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells. Biol Pharm Bull. 2002 Mar;25(3):393-6. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.